Cerebrospinal fluid ̇ b chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 310-319

  Letendre, Scott L ^a   Lanier, E Randall ^b   McCutchan, J Allen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; MACROPHAGE INFLAMMATORY PROTEIN 1; VIRUS RNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPROTECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CLINICAL TRIAL; COHORT ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PILOT STUDY; VIROLOGY;

ADULT; AIDS DEMENTIA COMPLEX; CD4 LYMPHOCYTE COUNT; CHEMOKINES, CC; COHORT STUDIES; HIV-1; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MULTIVARIATE ANALYSIS; PILOT PROJECTS; RANTES; RNA, VIRAL;

EID: 0033173462     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314866     Document Type: Article

References (52)

1. + lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997;126:929-38.
2. + lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann Intern Med 1997;126:939-45.
3. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
4. 4. Conrad AJ, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:425-35.
5. 5. Pratt RD, Nichols S, McKinney N, Kwok S, Dankner WM, Spector SA. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J Infect Dis 1996;174:288-93.
6. 6. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997;175:963-6.
7. 7. Ellis RJ, Hsia K, Spector S, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with AIDS. Ann Neurol 1997;42:679-88.
8. 8. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between HIV-associated dementia and viral load in CSF and brain. Ann Neurol 1997;42: 689-98.
9. 9. Wiley CA, Schrier RD, Nelson, JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-93.
10. 10. Bagasra O, Lavi E, Bobroski L, et al. Cellular reservoirs in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996;10: 573-85.
11. 11. Wesselingh SL, Glass J, McArthur JC, Griffin JW, Griffin DE. Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol 1994;4:199-206.
12. 12. DiStefano M, Wilt S, Gray F, Dubois-Dalcq M, Chiodi F.HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res Hum Retroviruses 1996;12:471-6.
13. 13. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755-62.
14. 14. Lipton SA, Gendelman HE. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332:934-40.
15. + T cell mediated suppression of HIV replication: β-chemokine dependent and independent effects. AIDS Res Hum Retroviruses 1997;13:63-9.
16. 16. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane. G protein coupled receptor. Science 1996;272:872-7.
17. 17. Alkhatib G, Combadiere C, Broder CC, et al. β CKR5: α RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
18. 18. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
19. 19. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevent infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
20. 20. He J, Chen V, Farzan M, et al. CCR3 and CCR-5 are co-receptors for HIV-1 infection of microglia. Nature 1997;385;645-9.
21. 21. Shich JT, Albright AV, Sharron M, et al. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol 1998;72:4243-9.
22. 22. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR-5 facilitate infection by primary HIV-1 isolates. Cell 1996;85: 1135-48.
23. + T cells. Science 1995;270:1811-5.
24. 24. Paxton WA, Martin SR, Tse D, el al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996;2:412-7.
25. 25. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P. The V3 domain of the HI-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 1996;2:1244-7.
26. 26. Lokensgard JR, Gekker G, Ehrlich LC, Hu S, Chao CC, Peterson PK. Proinflammatory cytokines inhibit HIV-1 (SF162) expression in acutely infected human brain cell cultures. J Immunol 1997;158:2449-55.
27. 27. Schmidtmayerova H, Nottet HS, Nuovo G, et al. Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996;93:700-4.
28. + alveolitis. Clin Exp Immunol 1994;96:187-92.
29. 29. Westmoreland SV, Rottman JB, Williams KC, Lackner AA, Sasseville VG. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol 1998;152:659-65.
30. 30. Schmidtmayerova H, Sherry B, Bukrinsky M. Chemokines and HIV replication. Nature 1996;382:767.
31. 31. Wagner L, Yang OO, Garcia-Zepeda EA, et al. β chemokines are released from HIV-1 specific cytolytic T-cell granules complexed to proteoglycans. Nature 1998;391:908-11.
32. 32. Kelly MD, Naif HM, Adams SI, Cunningham AL, Lloyd AR. Cutting edge: dichotomous effects of β chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol 1998;160:3091-5.
33. 33. Nuovo GJ, Alfieri ML. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 1996;2:358-66.
34. 34. Sasseville VG, Smith MM, Mackay CR, et al. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol 1996;149:1459-67.
35. 35. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE. β chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus associated dementia. Ann Neurol 1998;44:831-5.
36. 36. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158: 1079-83.
37. 37. Report of a working group of the American Academy of Neurology AIDS task force: nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type 1 infection. Neurology 1991;41:778-85.
38. 2-microglobulin in HIV-1 dementia. Neurology 1992;42:1707-12.
39. 39. Kim PJ, Jennrich RI. Tables of the exact sampling distribution of the two sample Kolmogorov-Smirnov criterion. In: Harter HL, Owen DB, eds. Selected tables in mathematical statistics. Providence, RI: American Mathematical Society. 1973.
40. 40. Schmid P, Conrad A, Syndulko K, et al. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr 1994;7:777-88.
41. 2 microglobulin in patients infected with human immunodeficiency virus. Neurology 1989;39:830-4.
42. 42. Wiley CA, Achim CL, Schrier RD, Heyes MP, McCutchan JA, Grant I. Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis. AIDS 1992;6:1299-307.
43. 2 microglobulin and the assessment of intra-blood-brain-barrier synthesis of HIV-specific and total IgG. J Clin Lab Analysis 1991;5:317-20.
44. 44. Canque B, Rosenzwajg M, Gey A, Tartuur E, Fridman WH, Gluckman JC. Macrophage inflammatory protein-1α is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 1996; 87:2011-9.
45. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA 1996;93: 14076-81.
46. 46. Persidsky Y, Stins M, Way D, et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997;158: 3499-510.
47. 47. Alkhatib G, Locati M, Kennedy PE, Murphy PM, Berger EA. HIV-1 coreceptor activity of CCR-5 and its inhibition by chemokines: independence from G protein signaling and importante of co-receptor downmodulation. Virology 1997;234:340-8.
48. 48. Trkola A, Paxton WA, Monard SP, et al. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J Virol 1998;72:396-404.
49. 49. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ. Cellular localization or the chemokine receptor CCR-5: correlation to cellular targets of HIV-1 infection. Am J Pathol 1997;151:1341-51.
50. 50. Bolin LM, Murray R, Lukacs NW, et al. Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol 1998;81:49-57.
51. 51. Pulliam L, Clarke JA, McGrath MS, Moore D, McGuire D. Monokine products as predictors of AIDS dementia. AIDS 1996;10:1495-500.
52. 52. Horuk R, Martin AW, Wang Z, et al. Expression of chemokine receptors by sunsets of neurons in the central nervous system. J Immunol 1997;158: 2882-90.